Chelsea Clinton invests in 24/7 pediatric startup

InnovationRx is a weekly digest of healthcare news. To receive it in your inbox, Subscribe here.

TThe U.S. health care system is not set up to care for a child who develops a rash or fever at 2 a.m. and may not be sick enough to end up in the emergency room, but whose parents can still see a doctor. not.there summer health The New York-based startup, which announced an $11.65 million Series A this week, offers 24/7, message-based access to a nationwide pediatrician within 15 minutes. “Our mission was to radically simplify access to healthcare,” Co-Founder and CEO Ellen DaSilva Said forbes. “We wanted to make it dramatically easier to care for your child when you need it.”

DaSilva is a mother of three, as are the investors who co-led the round. Alyssa Jaffee of 7wire ventures and Deena Shakir of Lux Capital. Both of us are regular users of Summer Health. Jaffee, Shakir and two other investors – chelsea clinton of metrodora ventures and alfred lin of Sequoia Capital – I am on the board of directors of a startup. Summer Health has raised approximately $19 million to date.

DaSilva said the company is also starting to offer services beyond just urgent care, including: specialty care, lactation consultants, sleep specialists, nutritionists, child behavior specialists, and more. Thousands of families have completed over 30,000 of his visits with Summer Health. Currently, the majority of the business is paid in cash, with subscriptions costing $45 per month per family. But Summer Health has also begun signing contracts with several employers and is looking for ways to expand.DaSilva suggested that Medicaid market In a blog post.she said forbes The company is expanding into other services, such as at-home diagnostics, such as an ear infection tool that connects to your smartphone.

The idea is not to replace pediatricians and in-person physical examinations, which are the core of a child’s health, but to support the overload of medical care between these visits. “We’re seeing deep synergies,” DaSilva said. “This is not a competitive product. We’re not taking business away from pediatricians. We’re helping them.”

How a decades-old medical records company made a big bet on AI to protect itself

Remember Allscripts? The 38-year-old electronic health records company rebranded to Veradime following a series of crises and was delisted from the Nasdaq in February. Now interim CEO Ying Ho is banking on the $140 million acquisition of AI startup Science IO to be the company’s key competitive advantage over other EHRs. It has bold plans to leverage data rights.

Please see here for the detail.

Pipeline and deal updates

Childhood cancer: The FDA has approved toborafenib, sold as Ojemda by Day One Biopharmaceuticals. This is the first approved treatment for recurrent childhood low-grade glioma, the most common brain tumor in children. The approval meets the company’s goal, which CEO Jeremy Bender said is to “bring new medicines to children with life-threatening diseases.”

Women’s health: Midi Health, a virtual clinic focused on menopause, has raised $60 million in Series B led by Emerson Collective. The California-based startup, which serves tens of thousands of patients across the country, said it plans to use the funding to hire 150 more clinicians by the end of the year.

Maternal health: Sibel Health, a provider of wireless patient monitoring devices for maternal health, received a $17.5 million grant from the Bill & Melinda Gates Foundation for labor triage and monitoring in low- and middle-income countries.

Bladder cancer: The FDA has approved ImmunityBio’s Anktiva in combination with BCG for non-muscle invasive bladder cancer. This treatment works by activating the body’s own immune response, T cells and natural killer cells, against the tumor.

AI for drug discovery: Xaira, the drug discovery AI company co-founded by Arch Ventures and Foresite Labs, announced it has raised more than $1 billion in funding with support from Arch, Foresite, Lux Capital, Menlo Ventures and others.

Immune diseases: Insight announced that it will acquire biotech startup Essient Pharmaceuticals for $750 million, giving the company access to Essient’s pipeline of immune disease treatments.

Remains of avian influenza virus found in U.S. milk supply; FDA says milk is safe

The Food and Drug Administration announced that samples of pasteurized milk from around the United States tested positive for remnants of H5N1 avian influenza. The findings come about a month after infections began spreading to dairy cows in several states, but not in U.S. milk, the Food and Drug Administration announced. Supply remains secure.

Please see here for the detail.

Other healthcare news

health insurance company humanQuarterly profit was reported at $741 million, boosting Medicare Advantage enrollment estimates.

support for legal abortion A Quinnipiac University poll found that 66% of voters think abortion should be legal in all or most cases, the highest percentage ever.

On Wednesday, supreme court He heard oral arguments on whether hospitals must provide abortions in emergency situations under federal law, even in states where abortion is prohibited.

patients treated female doctor New research shows that patients treated by male doctors have better outcomes.

surgeon New York University Langone Health The world’s first successful surgery combining a heart pump and gene-edited pig kidney transplant has been completed.

beyond forbes

Meet the fintech billionaire who made a fortune by rewarding home renters

Las Vegas Billionaire’s Bullet Train Construction Blueprint

The full story of the $46 million renewable energy scam

what else are you reading

Monkeypox virus: Dangerous strains become infectious through sex, new data suggests (Nature)

President Trump’s surrogates hint at how they could reshape US health care policy (STAT)

FTC Director Says Technological Advances Lead to Price-Fixing Risk in Healthcare (KFF Health News)